Nonetheless, macrophage amplification in LNs—for instance, via an induction of podoplanin expression in LECs or via blockade of CD200 or BST2—could help to activate endogenous as well as vaccine-induced tumor immunity [84]. The gene discussed is CD200; the disease is neoplasm.